International Business Machines Corp. (IBM) just dropped a bombshell in the chip world. On Thursday, the company unveiled what it's calling the world's first sub-1-nanometer chip technology — a 0.7nm chip that uses a brand-new three-dimensional "nanostack" transistor architecture. The idea is to keep Moore's Law alive by shrinking transistors beyond what current manufacturing can do.

Here's the headline number: this chip packs nearly 100 billion transistors onto a chip the size of a fingernail. That's almost double the density of IBM's 2-nanometer chip from 2021. For context, the most advanced chips today are around 3nm or 5nm, and IBM is already talking about something that's an order of magnitude smaller.

What does that mean for performance? IBM says the 0.7nm technology could deliver up to 50% higher performance or 70% greater energy efficiency compared to its 2nm chips. That's a huge leap, and it opens up possibilities for AI, cloud computing, and next-generation electronics where power and efficiency are everything.

But don't expect to buy a laptop with this chip next year. IBM says the earliest commercial adoption is probably five years out. That's typical for cutting-edge semiconductor research — the technology needs to be refined, manufacturing processes need to be developed, and partners like Samsung or Intel need to license it.

IBM Stock: What the Charts Say

IBM stock was down about 0.4% on Thursday, trading at $261.92. The broader market was also in the red, with the Nasdaq down 0.69% and the S&P 500 off 0.46%.

Technically, IBM is in a bit of a tug-of-war. The stock is trading 2.7% above its 50-day moving average of $252.38 and 2.5% above its 100-day moving average of $252.98. That sounds fine, but it's also 6.9% below its 20-day moving average of $278.54 and 5.3% below its 200-day moving average of $273.66. So short-term momentum is weak, but the longer-term trend is still positive.

The relative strength index (RSI) is at 46.88, which is neutral territory. That means neither buyers nor sellers are in control — the stock is just kind of hanging out.

One constructive sign: the 20-day moving average is still above the 50-day moving average, which is a short-term bullish signal. But the 50-day is below the 200-day, which keeps the longer-term trend under pressure. IBM has been consolidating between its May low and June high, so it's in a waiting pattern.

Key resistance is around $260.50, and support is at $212.50. The stock is currently just above resistance, so if it holds, that could be a bullish signal.

Earnings and Analyst Views

IBM's next big catalyst is its earnings report on July 22. Analysts expect earnings of $3.01 per share on revenue of $17.86 billion, up from $2.80 per share and $16.98 billion a year ago. That's solid growth, and the chip news could add some excitement.

Wall Street is generally bullish on IBM. The stock has a consensus Buy rating with an average price target of $301.07. Recent analyst moves include JPMorgan upgrading IBM to Overweight with a $291 target, Morgan Stanley raising its Equal-Weight target to $267, and Citigroup maintaining a Buy rating while lifting its target to $375. That last one is notably optimistic.

So IBM is in an interesting spot: a historic chip breakthrough that won't pay off for years, but solid near-term earnings momentum and analyst support. For long-term investors, the 0.7nm news is a reminder that IBM is still a serious player in semiconductor research. For traders, the stock's technical setup suggests a wait-and-see approach.